HOXA13 has been implicated in promoting IL-1β secretion and cytoskeletal remodeling in other cell types 69, and CTCF has been shown to dysregulate HOX gene transcription, including HOXA13, particularly in hematologic malignancies 70. Here, HOXA13 is linked to hematologic disorder.